Dr. Reddy's Gets VAI Status For US FDA Inspection At New York API Plant

Dr Reddy's Laboratories Ltd. on Monday said it has received the Establishment Inspection Report from the US Food and Drug Administration for its active pharmaceutical ingredient facility in New York.

The inspection has been classified as "voluntary action indicated" (VAI) and is now closed, the company said in an exchange filing.

A VAI classification means the FDA found some objectionable conditions or practices during the inspection, but does not intend to take any regulatory or enforcement action.